NewsWhore
04-26-2009, 10:30 PM
<img alt="" height="1" width="1">
Japan Stocks: Aozora, Chugai, Eiken, Hitachi, Takara Bio (http://news.google.com/news/url?sa=T&ct=us/2-0&fd=R&url=http://www.bloomberg.com/apps/news%3Fpid%3D20601101%26sid%3DaOpr5AYCsPGo%26refer%3Djapan&cid=1342056886&ei=gBr1ScXSAtywmAfIqo3eAQ&usg=AFQjCNHQwowhlrukrIaMpRAqTRRtE62QJQ)
Bloomberg
The drugmaker, which sells the antiviral drug Tamiflu, posted 13.8 billion yen in net income in the three months ended March 31, compared with 6.7 billion yen a year ago, boosted by an increase in drug sales and currency-exchange gains. ...
More... (http://news.google.com/news/url?sa=T&ct=us/2-0&fd=R&url=http://www.bloomberg.com/apps/news%3Fpid%3D20601101%26sid%3DaOpr5AYCsPGo%26refer%3Djapan&cid=1342056886&ei=gBr1ScXSAtywmAfIqo3eAQ&usg=AFQjCNHQwowhlrukrIaMpRAqTRRtE62QJQ)
Japan Stocks: Aozora, Chugai, Eiken, Hitachi, Takara Bio (http://news.google.com/news/url?sa=T&ct=us/2-0&fd=R&url=http://www.bloomberg.com/apps/news%3Fpid%3D20601101%26sid%3DaOpr5AYCsPGo%26refer%3Djapan&cid=1342056886&ei=gBr1ScXSAtywmAfIqo3eAQ&usg=AFQjCNHQwowhlrukrIaMpRAqTRRtE62QJQ)
Bloomberg
The drugmaker, which sells the antiviral drug Tamiflu, posted 13.8 billion yen in net income in the three months ended March 31, compared with 6.7 billion yen a year ago, boosted by an increase in drug sales and currency-exchange gains. ...
More... (http://news.google.com/news/url?sa=T&ct=us/2-0&fd=R&url=http://www.bloomberg.com/apps/news%3Fpid%3D20601101%26sid%3DaOpr5AYCsPGo%26refer%3Djapan&cid=1342056886&ei=gBr1ScXSAtywmAfIqo3eAQ&usg=AFQjCNHQwowhlrukrIaMpRAqTRRtE62QJQ)